Skip to content

Ginkgo Bioworks DNA Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Sana Biotechnology logo
Sana BiotechnologySANA
-$1.63M-19.0%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$1.43M+36.1%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$247K-61.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$653K-289%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$500K+105%
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets?
Ginkgo Bioworks (DNA) reported increase (decrease) in prepaid expense and other assets of -$5.93M in Q1 2026.
How has Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets changed year-over-year?
Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets decreased by 1120.7% year-over-year, from $581K to -$5.93M.
What is the long-term trend for Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets?
Over 2 years (2021 to 2024), Ginkgo Bioworks's increase (decrease) in prepaid expense and other assets has grown at a 67.2% compound annual growth rate (CAGR), from $3.61M to -$10.09M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.